The application of updating PIM-Taiwan criteria in clinic-visiting older patients with polypharmacy.

Chirn-Bin ChangHsiu-Yun LaiShinn-Jang HwangShu-Yu YangRu-Shu WuHsing-Cheng LiuDing-Cheng Chan

Published in: Therapeutic advances in drug safety (2018)

As there were significant differences in medication lists between PIM-Taiwan version 2010 and 2018, the prevalence of PIM and factors associated with PIM users varied accordingly. Physicians should pay special attention before prescribing BZDs which keep being the major leading PIM.

Keyphrases

primary care
working memory
adverse drug
healthcare
risk factors
physical activity
middle aged
community dwelling